Enovis reported a 7% increase in net sales to $384 million, with organic growth also at 7%. Adjusted earnings per share increased by 34% to $0.59. The company experienced a net loss of $(1.22) per diluted share. They updated 2022 outlook to include organic growth of approximately 6.5%, total sales growth of approximately 10%, adjusted EBITDA of $235-$240 million, and adjusted earnings per share of $2.20-$2.25.
Grew sales to $384 million, including 7% organic growth over the prior year quarter.
Reconstructive segment achieved double-digit growth.
Adjusted earnings per share increased 34% to $0.59.
Expanded core margins and extended its innovation momentum with several new product launches.
Enovis updated its expectations for 2022 full year performance to include organic growth of approximately 6.5%, total sales growth of approximately 10%, adjusted EBITDA of $235-$240 million, and adjusted earnings per share of $2.20-$2.25.